Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development
Logo Image
News|Webcasts|July 31, 2023

Driving Down Development Timelines Through Optimized Clinical Outsourcing Strategies and Flexible Operating Models

Author(s)IQVIA

Webinar Date/Time: Tuesday, September 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

How FSP is changing the way studies are outsourced, an investigation into the history, trends and key drivers of success for using functional service providers.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/clinical-outsourcing-strategies

Event Overview:

Ongoing challenges with cost and time-to-market have created increasing pressures for sponsors to optimize their clinical trial delivery. This webinar explores some of the key headwinds for clinical trial delivery in addition to the tools, technologies and processes that are being leveraged to address these. The evolution of outsourcing strategies is discussed along with a focus on diverse Functional Service Provider (FSP) models.

These FSP delivery models will be discussed, looking at how they can be leveraged to address specific needs and requirements, their pros and cons, as well as the key deciding factors for how and when they should be employed.

Key take-aways

  • How the industry approach to FSP is shifting and its impact on development costs and timelines
  • Which levers can be employed to mitigate the increasing costs and timelines for clinical trial delivery
  • How changes in outsourcing strategies are focusing on flexible delivery models
  • Not ‘one-size fits all’. How to identify optimal FSP strategies for your situation. Deep dive into the different types of FSP models, their pros and cons
  • How to set up and implement a successful FSP model


Speakers:

Ian Pemberton
VP, Clinical FSP
IQVIA

Ian has over 26 years in clinical research and has worked in Pharma Companies and CROs in that time in a number of operational and leadership roles. Ian has spent the last 16 years working in IQVIA in Clinical, Project Management, Regulatory & Start up roles with the last 3 years leading the setup, implementation and oversight of Clinical FSP Models.


Stephen Evans
VP, Clinical FSP
IQVIA

Stephen leads IQVIA’s large pharma clinical FSP group. He has spent 15 years at IQVIA across a number of clinical development and business development roles and immediately prior to working in Clinical FSP he led IQVIA’s Early Clinical Development unit within Project Leadership.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/clinical-outsourcing-strategies

Related to this article

View more
© photon_photo - © photon_photo - stock.adobe.com
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Read more
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
Read more
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Read more
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.
Read more
© putilov_denis - © putilov_denis - stock.adobe.com
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Read more